Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review
Cervical cancer rates in Sub-Saharan Africa (SSA) are amongst the highest worldwide. All three of the Human Papillomavirus (HPV) vaccines (9-valent, quadrivalent and bivalent HPV vaccine) provide primary protection against the most common cancer-causing strains of HPV (types 16 and 18) that are know...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-05-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/9/5/496 |
| _version_ | 1827692790962716672 |
|---|---|
| author | Caroline Deignan Alison Swartz Sara Cooper Christopher J. Colvin |
| author_facet | Caroline Deignan Alison Swartz Sara Cooper Christopher J. Colvin |
| author_sort | Caroline Deignan |
| collection | DOAJ |
| description | Cervical cancer rates in Sub-Saharan Africa (SSA) are amongst the highest worldwide. All three of the Human Papillomavirus (HPV) vaccines (9-valent, quadrivalent and bivalent HPV vaccine) provide primary protection against the most common cancer-causing strains of HPV (types 16 and 18) that are known to cause 70% of cervical cancers. Over the last five years, there has been an increase in Sub-Saharan African countries that have introduced the HPV vaccine. The majority of research has been conducted on supply-side barriers and facilitators to HPV vaccination uptake in SSA, yet little research has been conducted on demand-side or end-user perspectives of, and decisions around, HPV vaccination. In order to complement existing research, and inform current and future HPV vaccination implementation approaches, this qualitative systematic review explored Stakeholders’ understandings of HPV vaccination in SSA. This review searched the following databases: Embase (via Scopus), Scopus, MEDLINE (via PubMed), PubMed, EBSCOhost, Academic Search Premier, Africa-Wide Information, CINAHL, PsycARTICLES, PsycINFO, SocINDEX, Web of Science, and the Cochrane Controlled Register of Trials (CENTRAL) and found a total of 259 articles. Thirty-one studies were found eligible for inclusion and were analyzed thematically using Braun and Clarke’s methods for conducting a thematic analysis. The quality of included studies was assessed using the Critical Appraisal Skills Programme (CASP) checklist. Three major themes emerged from this analysis; knowledge of HPV vaccination and cervical cancer is intertwined with misinformation; fear has shaped contradictory perceptions about HPV vaccination and gender dynamics are relevant in how stakeholders understand HPV vaccination in SSA. |
| first_indexed | 2024-03-10T11:29:58Z |
| format | Article |
| id | doaj.art-a7e7c06f8d84405ba088b1297cffb5f8 |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-10T11:29:58Z |
| publishDate | 2021-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-a7e7c06f8d84405ba088b1297cffb5f82023-11-21T19:20:03ZengMDPI AGVaccines2076-393X2021-05-019549610.3390/vaccines9050496Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic ReviewCaroline Deignan0Alison Swartz1Sara Cooper2Christopher J. Colvin3The Division of Social and Behavioural Sciences, School of Public Health and Family Medicine, University of Cape Town, Cape Town 7935, South AfricaThe Division of Social and Behavioural Sciences, School of Public Health and Family Medicine, University of Cape Town, Cape Town 7935, South AfricaSouth African Medical Research Council, Cape Town 7501, South AfricaThe Division of Social and Behavioural Sciences, School of Public Health and Family Medicine, University of Cape Town, Cape Town 7935, South AfricaCervical cancer rates in Sub-Saharan Africa (SSA) are amongst the highest worldwide. All three of the Human Papillomavirus (HPV) vaccines (9-valent, quadrivalent and bivalent HPV vaccine) provide primary protection against the most common cancer-causing strains of HPV (types 16 and 18) that are known to cause 70% of cervical cancers. Over the last five years, there has been an increase in Sub-Saharan African countries that have introduced the HPV vaccine. The majority of research has been conducted on supply-side barriers and facilitators to HPV vaccination uptake in SSA, yet little research has been conducted on demand-side or end-user perspectives of, and decisions around, HPV vaccination. In order to complement existing research, and inform current and future HPV vaccination implementation approaches, this qualitative systematic review explored Stakeholders’ understandings of HPV vaccination in SSA. This review searched the following databases: Embase (via Scopus), Scopus, MEDLINE (via PubMed), PubMed, EBSCOhost, Academic Search Premier, Africa-Wide Information, CINAHL, PsycARTICLES, PsycINFO, SocINDEX, Web of Science, and the Cochrane Controlled Register of Trials (CENTRAL) and found a total of 259 articles. Thirty-one studies were found eligible for inclusion and were analyzed thematically using Braun and Clarke’s methods for conducting a thematic analysis. The quality of included studies was assessed using the Critical Appraisal Skills Programme (CASP) checklist. Three major themes emerged from this analysis; knowledge of HPV vaccination and cervical cancer is intertwined with misinformation; fear has shaped contradictory perceptions about HPV vaccination and gender dynamics are relevant in how stakeholders understand HPV vaccination in SSA.https://www.mdpi.com/2076-393X/9/5/496Human Papillomavirus (HPV)vaccinationSub-Saharan Africa (SSA)stakeholder understandingsrapid qualitative systematic reviewthematic analysis |
| spellingShingle | Caroline Deignan Alison Swartz Sara Cooper Christopher J. Colvin Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review Vaccines Human Papillomavirus (HPV) vaccination Sub-Saharan Africa (SSA) stakeholder understandings rapid qualitative systematic review thematic analysis |
| title | Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review |
| title_full | Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review |
| title_fullStr | Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review |
| title_full_unstemmed | Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review |
| title_short | Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review |
| title_sort | stakeholders understandings of human papillomavirus hpv vaccination in sub saharan africa a rapid qualitative systematic review |
| topic | Human Papillomavirus (HPV) vaccination Sub-Saharan Africa (SSA) stakeholder understandings rapid qualitative systematic review thematic analysis |
| url | https://www.mdpi.com/2076-393X/9/5/496 |
| work_keys_str_mv | AT carolinedeignan stakeholdersunderstandingsofhumanpapillomavirushpvvaccinationinsubsaharanafricaarapidqualitativesystematicreview AT alisonswartz stakeholdersunderstandingsofhumanpapillomavirushpvvaccinationinsubsaharanafricaarapidqualitativesystematicreview AT saracooper stakeholdersunderstandingsofhumanpapillomavirushpvvaccinationinsubsaharanafricaarapidqualitativesystematicreview AT christopherjcolvin stakeholdersunderstandingsofhumanpapillomavirushpvvaccinationinsubsaharanafricaarapidqualitativesystematicreview |